|
Aug 3rd, Sep 14 and Oct 19: "Utilizing
Kinase Inhibition Data
from Journal Articles and Patents in your Research". Protein kinases are now one of the most intensely
pursued classes of drug targets. Over 30 distinct kinase targets and over 200
kinase inhibitors are in clinical development. While currently most of the
clinical kinase drug targets are being investigated for treatment of cancer, a
growing number of other disorders including immunological, neurological,
metabolic and infectious diseases, have been associated with dysregulation of
protein phosphorylation.
Most of the current kinase inhibitors target the ATP
binding site of the kinase catalytic domain, despite the high degree of
conservation of the ATP site across the kinome. In fact, the clinical efficacy
of many of the current kinase inhibitor oncology drugs is now well understood
in terms of their polypharmacology – their ability to inhibit multiple kinase
at the same time. The development of novel efficacious and safe compounds thus
requires a finely tuned balance of polypharmacology and selectivity. Although
biochemical kinase profiling is now well established in discovery programs,
experimental testing of many compounds across hundreds of kinases can be very
expensive. With this Webinar series we want to introduce the Kinase Knowledge
Base (KKB): an extensive set of high-quality small molecule kinase inhibitor
data curated and standardized from scientific publications and patents as a
valuable resource to guide the discovery and development of novel targeted
kinase inhibitors as chemical probes and potential drug candidates.
AUG 3rd 2011: A RESOURCE OF HIGH-QUALITY
SMALL MOLECULE KINASE INHIBITOR DATA FROM LITERATURE AND PATENTS: THE KINASE
KNOWLEDGEBASE
This Webinar will provide an overview of the
Kinase Knowledgebase(KKB). We will discuss what types of information the KKB
contains; how data are annotated and standardized; how the information is
organized, details captured and data constantly growing to support modern
research.
View Slides
SEP
14th 2011: HOW KINASE INHIBITION DATA CAN BE
LEVERAGED IN PRACTICE.
We will
illustrate two scientific scenarios in which KKB can be used to inform a
research or development project to support decision making about how to move a
project forward or how to find entry points into a novel project. In on example we will focus on identifying
compounds of interest using the KKB based on chemotypes and kinase
activity. In another illustration we
will use KKB to charaterize compounds of interest by systematically annotating
them based on data available in the KKB, i.e. generating a KKB profile based on
reported activity / inhibition data.
This can be a useful first step to prioritize the most promising
compounds before committing significant resources to profile compounds of
interest experimentally.
Watch the recording using Adobe Flash (requires Adobe Flash plugin)
Watch the recording using QuickTime (requires Apple QuickTime plugin)
Download a sample data set of KKB mapped onto commercial libraries as discussed during the webinar (MS Excel format).
OCT
19th 2011: DEVELOPMENT OF PREDICTIVE MODELS AND VIRTUAL KINASE PROFILING UTILIZING KINASE KNOWLEDGEBASE DATA
In this
Webinar we will illustrate how KKB data an be used to develop predictive models
using machine learning and applying these models to virtually profile a set of
compounds of interest. By developing
predictive kinase models, we can essentially amplify the content of the KKB
(within a reasonable applicability domain) and thus extend the KKB profile
presented in Webinar 2 towards a virtual / predicted profile, to prioritize
compounds of interest. In addition we will illustrate the development of highly
predictive kinase classifiers and their potential for application to virtual
prioritization of compounds for kinase screening. With such an approach it may be possible to
avoid very large HTS campaigns and instead screen only 0.1 to 1 % of compounds
that were selected on a kinase predictor.
Watch the recording using Adobe Flash (requires Adobe Flash plugin)
Watch the recording using QuickTime (requires Apple QuickTime plugin)
|